Breaking News Instant updates and real-time market news.

GALT

Galectin Therapeutics

$1.54

-0.18 (-10.47%)

13:12
12/07/17
12/07
13:12
12/07/17
13:12

STAT's Feuerstein calls Wainwright note on Galectin 'embarrassing'

STAT's Adam Feuerstein just tweeted, "Re: $GALT - H.C. Wainwright published today one of the most embarrassing research notes you'll ever read. This is what they do. And yes, a stock offering is obviously coming...But I'm sure every trader having fun with $GALT today knows what's happening and won't be the last schmuck holding."

GALT Galectin Therapeutics
$1.54

-0.18 (-10.47%)

10/19/17
ROTH
10/19/17
INITIATION
Target $8
ROTH
Buy
Galectin Therapeutics initiated with a Buy at Roth Capital
Roth Capital analyst Yasmeen Rahimi started Galectin Therapeutics with a Buy rating and $8 price target based on her confidence in the clinical success of the company's lead compound for the treatment of liver cirrhosis.
11/28/17
HCWC
11/28/17
NO CHANGE
Target $6
HCWC
Buy
Galectin Therapeutics price target raised to $6 from $3.50 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce raised his price target for Galectin Therapeutics to $6 ahead of the Phase 2b NASH-CX trial readout, which he expects next week. With few therapeutic options in development for the most severely afflicted nonalcoholic steatohepatitis patients, the approvability bar is fairly low, Arce tells investors in a research note. He keeps a Buy rating on Galectin ahead of the NASH-CX readout.
12/07/17
HCWC
12/07/17
NO CHANGE
Target $10
HCWC
Buy
H.C. Wainwright says market wrong, ups Galectin target to $10
H.C. Wainwright analyst Ed Arce raised his price target for Galectin Therapeutics to $10 from $6 saying the market got wrong, "again," the company's Phase 2b NASH-CX trial results, which featured a miss on the overall primary efficacy endpoint. The corresponding stock selloff reflects the "inability of many biotech investors to recognize any value from a trial result that does not myopically present as a 'clean in,'" Arce tells investors in a research note. He believes the study is a "landmark" for the treatment of cirrhosis, "not only because it appears to offer the first ever pharmacological benefit in NASH cirrhosis (across several parameters), but also because it defines a highly clinically significant and easily identifiable patient sub-population for treatment: cirrhotics with mild portal hypertension." The analyst sees multiple paths available to Galectin for a registrational Phase 3 program and he reaffirms his Buy rating on the shares.
12/07/17
ROTH
12/07/17
NO CHANGE
Target $3
ROTH
Buy
Galectin Therapeutics price target lowered to $3 from $10 at Roth Capital
Roth Capital analyst Yasmeen Rahimi lowered her price target for Galectin Therapeutics to $3 from $10 after the company announced that its Phase 2b NASHCX trial in 161 cirrhotic NASH patients missed its primary endpoint. However, the analyst still sees a few positive points such as clean safety, and reiterates a Buy rating on the shares.

TODAY'S FREE FLY STORIES

SAGE

Sage Therapeutics

$158.03

-6.62 (-4.02%)

17:25
12/14/17
12/14
17:25
12/14/17
17:25
Conference/Events
Sage Therapeutics management to meet with RBC Capital »

Dinner Meeting will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

ORCL

Oracle

$50.20

0.14 (0.28%)

17:24
12/14/17
12/14
17:24
12/14/17
17:24
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle CEO Hurd says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ADBE

Adobe

$175.00

-1.83 (-1.03%)

17:23
12/14/17
12/14
17:23
12/14/17
17:23
Hot Stocks
Adobe targeting subscription bookings growth of 20% in FY18 »

Says expect quarterly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ADBE

Adobe

$175.00

-1.83 (-1.03%)

17:20
12/14/17
12/14
17:20
12/14/17
17:20
Hot Stocks
Adobe says advertising cloud had a 'strong' year »

Says advertising cloud…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ORCL

Oracle

$50.19

0.14 (0.28%)

17:20
12/14/17
12/14
17:20
12/14/17
17:20
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle says currency…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ORCL

Oracle

$50.19

0.14 (0.28%)

17:19
12/14/17
12/14
17:19
12/14/17
17:19
Earnings
Oracle sees Q3 adjusted EPS 68c-70c, consensus 72c »

Sees Q3 revenue growth of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

UBA

Urstadt Biddle

$22.71

-0.48 (-2.07%)

, UBP

Urstadt Biddle Properties Inc.

$18.00

-0.01 (-0.06%)

17:17
12/14/17
12/14
17:17
12/14/17
17:17
Hot Stocks
Urstadt Biddle raises quarterly dividend by 0.5c to 27c »

At their regular meeting…

UBA

Urstadt Biddle

$22.71

-0.48 (-2.07%)

UBP

Urstadt Biddle Properties Inc.

$18.00

-0.01 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$50.19

0.14 (0.28%)

17:14
12/14/17
12/14
17:14
12/14/17
17:14
Hot Stocks
Oracle says customer adoption of cloud products 'remains very strong' »

Says expects to continue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

NQ

NQ Mobile

$4.13

0.02 (0.49%)

17:14
12/14/17
12/14
17:14
12/14/17
17:14
Hot Stocks
NQ Mobile announces partnership with Chery Automotive »

NQ Mobile Inc announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

CVX

Chevron

$119.53

-0.4 (-0.33%)

, SLB

Schlumberger

$62.37

-0.93 (-1.47%)

17:12
12/14/17
12/14
17:12
12/14/17
17:12
Periodicals
Chevron near pact with Schlumberger to drill six Brazil wells, Reuters says »

Chevron (CVX) has reached…

CVX

Chevron

$119.53

-0.4 (-0.33%)

SLB

Schlumberger

$62.37

-0.93 (-1.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

VSTM

Verastem

$3.65

-0.15 (-3.95%)

17:07
12/14/17
12/14
17:07
12/14/17
17:07
Syndicate
Verastem files to sell $25M of common stock »

BTIG is acting as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNR

Denbury Resources

$1.62

0.02 (1.25%)

17:06
12/14/17
12/14
17:06
12/14/17
17:06
Syndicate
Breaking Syndicate news story on Denbury Resources »

Denbury Resources files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCBS

Nicolet Bankshares

$56.52

-1.12 (-1.94%)

17:05
12/14/17
12/14
17:05
12/14/17
17:05
Initiation
Nicolet Bankshares initiated  »

Nicolet Bankshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GALE

Galena

$0.32

0.0399 (14.24%)

17:05
12/14/17
12/14
17:05
12/14/17
17:05
Hot Stocks
Galena to adjourn special meeting until Friday, December 29 »

Galena Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDS

FactSet

$202.46

0.44 (0.22%)

17:04
12/14/17
12/14
17:04
12/14/17
17:04
Initiation
FactSet initiated  »

FactSet initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

UTX

United Technologies

$123.76

-0.54 (-0.43%)

17:04
12/14/17
12/14
17:04
12/14/17
17:04
Hot Stocks
United Technologies awarded $6.7B U.S. Air Force contract »

United Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNPR

Juniper

$28.80

-0.31 (-1.06%)

17:03
12/14/17
12/14
17:03
12/14/17
17:03
Initiation
Juniper initiated  »

Juniper resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$37.90

-0.25 (-0.66%)

17:03
12/14/17
12/14
17:03
12/14/17
17:03
Initiation
Cisco initiated  »

Cisco resumed with a Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

ANET

Arista Networks

$226.72

1.59 (0.71%)

17:02
12/14/17
12/14
17:02
12/14/17
17:02
Initiation
Arista Networks initiated  »

Arista Networks resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

GRA

W.R. Grace

$69.98

-0.46 (-0.65%)

, ALB

Albemarle

$127.58

-2.2 (-1.70%)

17:01
12/14/17
12/14
17:01
12/14/17
17:01
Hot Stocks
W.R. Grace to acquire Polyolefin Catalysts unit of Albemarle for $416M »

W.R. Grace (GRA) signed…

GRA

W.R. Grace

$69.98

-0.46 (-0.65%)

ALB

Albemarle

$127.58

-2.2 (-1.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

LENS

Presbia

$1.93

-0.25 (-11.47%)

16:59
12/14/17
12/14
16:59
12/14/17
16:59
Hot Stocks
Presbia executive chairman resigns as company reorders operational priorities »

Presbia announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HES

Hess Corp.

$42.67

-1.43 (-3.24%)

16:58
12/14/17
12/14
16:58
12/14/17
16:58
Periodicals
Elliot seeks ouster of Hess Corp. CEO, or sale of company, WSJ reports »

Elliott Management is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDR

DDR Corp.

$7.96

-0.11 (-1.36%)

16:52
12/14/17
12/14
16:52
12/14/17
16:52
Hot Stocks
Breaking Hot Stocks news story on DDR Corp. »

DDR Corp up 8.7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDXC

ChromaDex

$6.24

-0.3 (-4.59%)

16:52
12/14/17
12/14
16:52
12/14/17
16:52
Syndicate
Breaking Syndicate news story on ChromaDex »

ChromaDex files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HES

Hess Corp.

$42.67

-1.43 (-3.24%)

16:51
12/14/17
12/14
16:51
12/14/17
16:51
Hot Stocks
Hess Corp. up 6.5% after DJ reports Elliot seeks to replace CEO »

In after-hours trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.